Fred Alger Management, LLC Biodesix Inc Transaction History

Fred Alger Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.32 - $2.12 $3,441 - $5,526	-2,607 Reduced 1.95%	130,908 $215,000
Q1 2022 May 16, 2022	SELL	$1.69 - $5.81 $1,319 - $4,537	-781 Reduced 0.58%	133,515 $226,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $8.67 $20,286 - $43,003	-4,960 Reduced 3.56%	134,296 $710,000
Q3 2021 Nov 15, 2021	BUY	$6.6 - $12.78 $13,292 - $25,738	2,014 Added 1.47%	139,256 $1.15 Million
Q2 2021 Aug 16, 2021	SELL	$12.14 - $20.35 $22,628 - $37,932	-1,864 Reduced 1.34%	137,242 $1.81 Million
Q1 2021 May 17, 2021	SELL	$16.87 - $31.21 $30,838 - $57,051	-1,828 Reduced 1.3%	139,106 $2.83 Million
Q4 2020 Feb 16, 2021	BUY	$10.89 - $20.16 $1.53 Million - $2.84 Million	140,934 New	140,934 $2.84 Million

62.3M

2.6K

10.1K

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $55.2M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.